Drug Literature Evaluation: Beyond the Randomized, Controlled Clinical Trial

Sunday, December 2, 2012
8:00 AM – 9:30 AM

Planned in cooperation with the ASHP New Practitioners Forum
Activity #: 204-000-12-310-L04P
Level of Content: Intermediate
1.50 Contact Hours / Knowledge-based
Program Chair: Robert D. Beckett, PharmD, BCPS

Learning Objectives:

• Interpret key components of commonly encountered study designs.
  
• Assess the biostatistical methods used in commonly encountered study designs.
  
• Evaluate a piece of drug literature for appropriateness, strengths, limitations, and impact on practice.